Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-07-24
2008-12-09
Blanchard, David J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C424S130100, C424S133100, C424S158100, C424S172100
Reexamination Certificate
active
07462698
ABSTRACT:
The present invention provides novel anti-CD26 antibodies and other, related polypeptides, as well as novel polynucleotides encoding the antibodies and polypeptides. The invention also provides methods of making the antibodies and polypeptides. Compositions and cells comprising the antibodies or polypeptides are further provided. Methods of using the antibodies and/or polypeptides, such as to inhibit cell proliferation and in the treatment of conditions associated with CD26, are also provided.
REFERENCES:
patent: 4485045 (1984-11-01), Regen
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 4777127 (1988-10-01), Suni et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5017487 (1991-05-01), Stunnenberg et al.
patent: 5047335 (1991-09-01), Paulson et al.
patent: 5075109 (1991-12-01), Tice et al.
patent: 5120642 (1992-06-01), Schlossman et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5278299 (1994-01-01), Wong et al.
patent: 5422120 (1995-06-01), Kim
patent: 5510261 (1996-04-01), Goochee et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5580717 (1996-12-01), Dower et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5739277 (1998-04-01), Presta et al.
patent: 5750373 (1998-05-01), Garrard et al.
patent: 5814482 (1998-09-01), Dubensky, Jr. et al.
patent: 5866692 (1999-02-01), Shitara et al.
patent: 5997867 (1999-12-01), Waldmann et al.
patent: 6054297 (2000-04-01), Carter et al.
patent: 6180377 (2001-01-01), Morgan et al.
patent: 6210671 (2001-04-01), Co
patent: 6265150 (2001-07-01), Terstappen et al.
patent: 6265551 (2001-07-01), Duke-Cohan et al.
patent: 6325989 (2001-12-01), Duke-Cohan et al.
patent: 6350861 (2002-02-01), Co et al.
patent: 6376471 (2002-04-01), Lawrence, III et al.
patent: 6413942 (2002-07-01), Felgner et al.
patent: 6436908 (2002-08-01), Koch et al.
patent: 6573096 (2003-06-01), Chen
patent: 7117096 (2006-10-01), Luo et al.
patent: 7198788 (2007-04-01), Dang et al.
patent: 2002/0132979 (2002-09-01), Chen
patent: 2002/0177170 (2002-11-01), Luo et al.
patent: 2003/0022240 (2003-01-01), Luo et al.
patent: 2003/0031665 (2003-02-01), Dang et al.
patent: 2004/0010376 (2004-01-01), Luo et al.
patent: 2004/0115202 (2004-06-01), Chen
patent: 2004/0133357 (2004-07-01), Zhong et al.
patent: 2005/0084928 (2005-04-01), Birch et al.
patent: 2005/0170454 (2005-08-01), Mainwaring et al.
patent: 2006/0003405 (2006-01-01), Kallmeier et al.
patent: 2006/0093553 (2006-05-01), Dang et al.
patent: 2007/0009526 (2007-01-01), Benson et al.
patent: 2007/0037214 (2007-02-01), Luo et al.
patent: 2007/0060528 (2007-03-01), Christopher et al.
patent: 2007/0105771 (2007-05-01), Aoyagi et al.
patent: 2007/0207143 (2007-09-01), Dang et al.
patent: 2007/0259824 (2007-11-01), Morimoto et al.
patent: 0 345 242 (1989-12-01), None
patent: 0 345 242 (1989-12-01), None
patent: 0 519 596 (1992-12-01), None
patent: 0 524 968 (1993-02-01), None
patent: 0 524 968 (1993-02-01), None
patent: 0 524 968 (1993-02-01), None
patent: 2 200 651 (1988-08-01), None
patent: WO-89/01973 (1989-03-01), None
patent: WO-89/01973 (1989-03-01), None
patent: WO-90/07936 (1990-07-01), None
patent: WO-90/11092 (1990-10-01), None
patent: WO-91/00360 (1991-01-01), None
patent: WO-91/02805 (1991-03-01), None
patent: WO-91/07985 (1991-06-01), None
patent: WO-91/14445 (1991-10-01), None
patent: WO-92/20373 (1992-11-01), None
patent: WO-93/03769 (1993-03-01), None
patent: WO-93/06213 (1993-04-01), None
patent: WO-93/10218 (1993-05-01), None
patent: WO-93/11230 (1993-06-01), None
patent: WO-93/16102 (1993-08-01), None
patent: WO-93/19191 (1993-09-01), None
patent: WO-93/25234 (1993-12-01), None
patent: WO-93/25698 (1993-12-01), None
patent: WO-94/03622 (1994-02-01), None
patent: WO-94/04690 (1994-03-01), None
patent: WO-94/09132 (1994-04-01), None
patent: WO-94/12649 (1994-06-01), None
patent: WO-94/12649 (1994-06-01), None
patent: WO-94/23697 (1994-10-01), None
patent: WO-94/28938 (1994-12-01), None
patent: WO-95/00655 (1995-01-01), None
patent: WO-95/07944 (1995-03-01), None
patent: WO-95/11984 (1995-05-01), None
patent: WO-95/11984 (1995-05-01), None
patent: WO-95/13796 (1995-05-01), None
patent: WO-95/30763 (1995-11-01), None
patent: WO-95/30763 (1995-11-01), None
patent: WO-96/17072 (1996-06-01), None
patent: WO-96/17072 (1996-06-01), None
patent: WO-96/38550 (1996-12-01), None
patent: WO-97/42338 (1997-11-01), None
patent: WO-99/58572 (1999-11-01), None
patent: WO-01/27160 (2001-04-01), None
patent: WO-01/74299 (2001-10-01), None
patent: WO-01/74299 (2001-10-01), None
patent: WO-02/084277 (2002-10-01), None
patent: WO-02/092127 (2002-11-01), None
patent: WO-03/035696 (2003-05-01), None
patent: WO-03/035696 (2003-05-01), None
patent: WO-03/054172 (2003-07-01), None
patent: WO-03/054172 (2003-07-01), None
patent: WO-03/064630 (2003-08-01), None
patent: WO-03/064630 (2003-08-01), None
patent: WO-03/099999 (2003-12-01), None
patent: WO-03/099999 (2003-12-01), None
patent: WO-2004/009823 (2004-01-01), None
patent: WO-2004/045497 (2004-06-01), None
patent: WO-2004/045497 (2004-06-01), None
patent: WO-2004/058184 (2004-07-01), None
patent: WO-2004/058184 (2004-07-01), None
patent: WO-2005/054273 (2005-06-01), None
patent: WO-2005/054273 (2005-06-01), None
patent: WO-2005/063170 (2005-07-01), None
patent: WO-2005/063170 (2005-07-01), None
patent: WO-2007/005955 (2007-01-01), None
patent: WO-2007/014169 (2007-02-01), None
patent: WO-2007/014169 (2007-02-01), None
Adelman, J.P. et al. (1983), “In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone,”DNA2(3): 183-193.
Al-Lazikani, B. et al. (Nov. 7, 1997), “Standard Conformations for the Canonical Structures of Immunoglobulins,”J. Molec. Biol.273(4):927-948.
Altschul, S.F. et al. (Oct. 5, 1990). “Basic Local Alignment Search Tool,”J. Mol. Biol.215(3):403-410.
Altschul, S.F. et al. (1996). “Local Alignment Statistics” Chapter 27 InMethods In Enzymology, Doolittle, R.F. ed., Academic Press, Inc.: San Diego, CA 266:460-480.
Altschul, S.F. et al. (Sep. 1, 1997). “Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs,”Nucleic Acids Res.25(17):3389-3402.
Aratake, Y. et al. (Sep. 1991). “Dipeptidyl Aminopeptidase IV Staining of Cytologic Preparations to Distinguish Benign from Malignant Thyroid Diseases,”Am. J. Clin. Pathol.96(3):306-310.
Aytac, U. et al. (Oct. 1, 2001). “Expression of CD26 and Its Associated Dipeptidyl Peptidase IV Enzyme Activity Enhances Sensitivity to Doxorubicin-Induced Cell Cycle Arrest at the G2/M Checkpoint,”Cancer Res.61(19):7204-7210.
Aytac, U. et al. (Feb 10, 2003). “Effect of CD26/Dipeptidyl Peptidase IV on Jurkat Sensitivity to G2/M Arrest Induced by Topoisimerase II Inhibitors,”British Journal of Cancer88(3):455-462.
Bach, J-F. et al. (1985). “Monoclonal Antibodies as Therapeutic Tools in Medicine” Chapter 22In Handbook of Monoclonal Antibodies, Ferrone, S. et al. eds., Noyes Puiblications: Park Ridge, NJ, pp. 419-435.
Barbas III, C.F. et al. (Apr. 26, 1994). “In Vitro Evolution of a Neutralizing Human Antibody to Human Immunodeficiency Virus Type 1 to Enhance Affinity and Broaden Strain Cross-Reactivity,”Proc. Natl. Acad. Sci. USA91(9):3809-3813.
Bauvois, B. et al. (Mar. 1999), “Constitutive Expression of CD26/Dipeptidylpeptidase IV on Peripheral Blood B Lymphocytes of Patients with B Chronic Lumphocytic Leukaemia,”Br. J. Cancer.79(7/8):1042-1048.
Berkner, K.L.
Aoyagi Teikichi
Hsieh Mark
Li Yan
Luo Peter Peizhi
Morimoto Chikao
Blanchard David J.
Gussow Anne M.
Morrison & Foerster / LLP
Y's Therapeutics Co., Ltd.
LandOfFree
Anti-CD26 antibodies and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-CD26 antibodies and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-CD26 antibodies and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4042995